Start with its own history
At 21.83×, LH is 15.2% above its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
NYSE · LHMedical - Diagnostics & ResearchUpdated Nov 4, 2026
Labcorp Holdings Inc. P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
21.83×
15.2% abovethe 10-year annual average
Share price367.79
÷Earnings per share16.85
Price and EPS in quote currency. Calculation details
Investors are paying 21.83 for every 1 of reported earnings per share.
P/E over time
2016 – 2025
Annual P/ESelected-period average 18.95×
3-year average32.32×3 positive annual observations
5-year average24.47×5 positive annual observations
10-year average18.95×10 positive annual observations
Peer median · TTM25.12×5 peers with positive P/E
Historical P/E ratios
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2025 | 23.80× | -7.7% |
| Dec 31, 2024 | 25.80× | -45.5% |
| Dec 31, 2023 | 47.35× | +228.6% |
| Dec 31, 2022 | 14.41× | +31.2% |
| Dec 31, 2021 | 10.98× | +0.4% |
| Dec 31, 2020 | 10.94× | -36.7% |
| Dec 31, 2019 | 17.28× | +38.7% |
| Dec 31, 2018 | 12.46× | +12.7% |
View all 25 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2017 | 11.06× | -28.4% |
| Dec 31, 2016 | 15.45× | -35.7% |
| Dec 31, 2015 | 24.03× | +56.3% |
| Dec 31, 2014 | 15.37× | +31.2% |
| Dec 31, 2013 | 11.71× | -1.8% |
| Dec 31, 2012 | 11.92× | -14.3% |
| Dec 31, 2011 | 13.91× | +0.4% |
| Dec 31, 2010 | 13.86× | +7.4% |
| Dec 31, 2009 | 12.91× | +7.3% |
| Dec 31, 2008 | 12.03× | -24.4% |
| Dec 31, 2007 | 15.90× | -12.3% |
| Dec 31, 2006 | 18.14× | +13.3% |
| Dec 31, 2005 | 16.01× | -2.8% |
| Dec 31, 2004 | 16.46× | +15.7% |
| Dec 31, 2003 | 14.23× | +26.9% |
| Dec 31, 2002 | 11.21× | -58.3% |
| Dec 31, 2001 | 26.92× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How LH compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 LH This stockLabcorp Holdings Inc. | 21.83× |
 DGXQuest Diagnostics Incorporated | 25.12× |
 SKHCFSonic Healthcare Limited | 15.75× |
 NTRANatera, Inc. | N/M |
 GHGuardant Health, Inc. | N/M |
 ERFSFEurofins Scientific SE | 29.34× |
 BMXXYbioMérieux S.A. | 24.85× |
 QGENQiagen N.V. | 26.07× |
 GRALGRAIL Inc. | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does LH’s P/E tell you?
Compare like with like
The median of the 5 positive peer ratios above is 25.12×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take LH into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("LH", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 367.79 ÷ EPS 16.85 = 21.83×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 4, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
LH P/E ratio: common questions
The essentials behind the numbers.
Labcorp Holdings Inc.'s current P/E is 21.83× based on the quote data last updated Nov 4, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.